Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the progression of the disease. Optimal use of advanced imaging techniques or biomarkers may facilitate early diagnosis of RA. Even though many disease-modifying anti-rheumatic drugs (DMARDs) are available...
Saved in:
Main Authors: | Bruno Fautrel, Josef S Smolen, Fabrizio Benedetti, Roberto Caporali, Thomas Doerner, Burkhard Pieper, Minjun Jang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-06-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/7/2/e001637.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinguishing rheumatoid arthritis from psoriatic arthritis
by: Joseph F Merola, et al.
Published: (2018-08-01) -
Wnt signaling as a translational target in rheumatoid and psoriatic arthritis
by: Gloria Riitano, et al.
Published: (2025-02-01) -
Targeted Therapy for Rheumatoid Arthritis in the New Era
by: WANG Jun, et al.
Published: (2025-01-01) -
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
by: Xavier Mariette, et al.
Published: (2022-02-01) -
Clinical and Immunological Characteristics of Elderly Onset Rheumatoid Arthritis
by: LI Zhengfang, et al.
Published: (2025-01-01)